Jacques Messier
Amministratore Delegato presso The Toronto Humane Society
Profilo
Jacques Messier is currently the Co-Chief Executive Officer at The Toronto Humane Society.
He previously served as the President & Chief Executive Officer at Novopharm Ltd.
from 1995 to 2001.
From 2004 to 2007, he was the Chief Executive Officer at Semex Alliance, Inc. He also held the position of Independent Director at Nuvo Pharmaceuticals, Inc. from 2004 to 2019.
Dr. Messier has an MBA from the University of Western Ontario.
Posizioni attive di Jacques Messier
Società | Posizione | Inizio |
---|---|---|
The Toronto Humane Society
The Toronto Humane Society Miscellaneous Commercial ServicesCommercial Services The Toronto Humane Society provides public spay neuter services for cats and dogs. It specializes in animal adoption, animal intake, foster, volunteer program, and animal advocacy, spay/neuter services, animal vaccine services, pet food bank, youth education, trap, neuter, return program, working with other shelters, rescues and municipal animal services and animal care. The company was founded in 1887 by John J. Kelso and is headquartered in Toronto, Canada. | Amministratore Delegato | 01/09/2011 |
Precedenti posizioni note di Jacques Messier
Società | Posizione | Fine |
---|---|---|
NUVO PHARMACEUTICALS INC. | Direttore/Membro del Consiglio | 24/06/2019 |
Semex Alliance, Inc.
Semex Alliance, Inc. Food DistributorsDistribution Services Semex Alliance, Inc. develops bovine genetic solutions for producers in Canada and internationally. The firm offers dairy and beef genetics, and embryos through its distributor network in Canada, the United States, Latin America, Africa, the Asia Pacific, the Middle East, and Eastern and Western Europe. Its solutions include Repromax, Healthsmart, Genomax, Genomax+, Semexx, Repromix, Calving Ease and Robot Ready. The company was founded in 1997 and is headquartered in Guelph, Canada. | Presidente | 01/01/2007 |
AMAG Pharma USA, Inc.
AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharma USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | Direttore operativo | 01/01/2003 |
Novopharm Ltd.
Novopharm Ltd. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., Novopharm Ltd. is a Canadian company that develops pharmaceutical products. The company is based in Toronto, Canada. Novopharm was acquired by Teva Pharmaceutical Industries Ltd. on February 01, 2000. The company was founded by Leslie Lewis Dan. | Presidente | 01/01/2001 |
National Center for Biotechnology Information | Corporate Officer/Principal | - |
Formazione di Jacques Messier
University of Western Ontario | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 7 |
---|---|
AMAG Pharma USA, Inc.
AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharma USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | Health Technology |
Nuvo Pharmaceuticals, Inc.
Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |
Novopharm Ltd.
Novopharm Ltd. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., Novopharm Ltd. is a Canadian company that develops pharmaceutical products. The company is based in Toronto, Canada. Novopharm was acquired by Teva Pharmaceutical Industries Ltd. on February 01, 2000. The company was founded by Leslie Lewis Dan. | Health Technology |
Semex Alliance, Inc.
Semex Alliance, Inc. Food DistributorsDistribution Services Semex Alliance, Inc. develops bovine genetic solutions for producers in Canada and internationally. The firm offers dairy and beef genetics, and embryos through its distributor network in Canada, the United States, Latin America, Africa, the Asia Pacific, the Middle East, and Eastern and Western Europe. Its solutions include Repromax, Healthsmart, Genomax, Genomax+, Semexx, Repromix, Calving Ease and Robot Ready. The company was founded in 1997 and is headquartered in Guelph, Canada. | Distribution Services |
National Income Protection Plan | |
The Toronto Humane Society
The Toronto Humane Society Miscellaneous Commercial ServicesCommercial Services The Toronto Humane Society provides public spay neuter services for cats and dogs. It specializes in animal adoption, animal intake, foster, volunteer program, and animal advocacy, spay/neuter services, animal vaccine services, pet food bank, youth education, trap, neuter, return program, working with other shelters, rescues and municipal animal services and animal care. The company was founded in 1887 by John J. Kelso and is headquartered in Toronto, Canada. | Commercial Services |
National Center for Biotechnology Information | Government |
- Borsa valori
- Insiders
- Jacques Messier